MSL
SRNE

Mackay Shields LLC’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Mackay Shields LLC’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-69,100
Closed -$572K – 1429
2021
Q1 		$572K Sell
69,100
-25,500
-27% -$211K ﹤0.01% 1171
2020
Q4 		$646K Buy
94,600
+27,500
+41% +$188K ﹤0.01% 1190
2020
Q3 		$748K Buy
+67,100
New +$748K 0.01% 1095